Pharmaceutical Technology

JUNE 24, 2022

invoX Pharma has signed a definitive agreement for the acquisition of all issued and outstanding shares of clinical-stage biopharma firm F-star Therapeutics, in a deal valued at nearly $161m or $7.12 invoX Pharma is a fully owned Sino Biopharmaceutical subsidiary. for each share in cash.

Biopharma 64

Biopharma Pharma Pharmacology Healthcare 64

MedCity News

JUNE 16, 2023

Numerous clinical, regulatory and financial factors are behind this digital shift in pharma. UCHealth providers are also notified of these potential changes and can intervene directly if warranted, driving the next level of tech-enabled personalized healthcare.

Pharma 101

Pharma Food and Drug Administration Recruitment Pharmacology 101

Clarivate

DECEMBER 14, 2023

Here are a few trends in life sciences and healthcare our analysts are keeping an eye on – and what they expect to see in 2024: Move over, oncology – metabolic drugs are the new hotness: The successful launches of Novo Nordisk’s Wegovy® and Eli Lilly’s Mounjaro® represent a revolutionary pharmacological breakthrough of rare proportions.

Pharma 111

Pharma Pharmacology Government Healthcare 111

Clarivate

FEBRUARY 28, 2023

Using real world data to analyze LHON dynamics To better understand the dynamics of LHON, including disease prevalence and drug usage in the United States, we analyzed real world data from electronic health records (EHR), claims and pharmacy data from healthcare institutions and providers. The Clarivate U.S. ” Ophthalmology; V.127;

Prescription 98

Prescription Patients Pharmacology Healthcare 98